Trial intelligence / Profile preview

Suboxone treatment and recovery trial

ISRCTN41645723Phase 4Completed

Sponsor
National Rehabilitation Center
Start
Sep 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of Suboxone in opioid use disorder (OUD) (2 arms), sponsored by National Rehabilitation Center. Primary endpoint: Mean percentage of urine drug screens negative for opioids. Started Sep 2014; status: completed.

02

Drugs

Suboxone
03

Conditions

opioid use disorder (OUD)

Beyond the preview

Go deeper on ISRCTN41645723.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN41645723.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call